Ying Han 4
4 · GYRE THERAPEUTICS, INC. · Filed Aug 16, 2024
Insider Transaction Report
Form 4
Ying Han
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-08-14+341,000→ 341,000 totalExercise: $9.98Exp: 2034-08-14→ Common Stock (341,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 341,000 shares of the Issuer's common stock, 25% of which will vest on August 14, 2025, with the remaining vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.